高级检索
当前位置: 首页 > 详情页

Ginsenoside Rg1 reduces toxicity of fine particulate matter on human alveolar epithelial cells: A preliminary observation

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]China Acad Chinese Med Sci, Inst Basic Theory, Beijing 100700, Peoples R China [2]China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China [3]China Japan Friendship Hosp, Inst Clin Med, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: ginsenoside Rg1 fine particulate matter human alveolar epithelial cells cytotoxicity

摘要:
Fine particulate matter (PM2.5) is a significant environmental pollutant responsible for a number of human diseases. Ginsenoside Rg1 (Rg1) is likely to have the potential to relieve PM2.5-induced cell injury. The present study is designed to preliminarily observe the harmful effect of PM2.5 and the protective effect of Rg1 against PM2.5 on human A549 lung epithelial cells in vitro. The cytotoxic effects of the PM2.5 or Rg1 on A549 cells were measured by means of cell viability, and then exposure concentration of PM2.5 and pretreatment concentration of Rg1 used in the following assays were established. The A549 cells were pretreated with Rg1 for 1 h and then exposed to PM2.5 for 24 h. The levels of lactate dehydrogenase (LDH) in the cell culture supernatant and malondialdehyde (MDA) within the cells were assayed. The present results revealed that 200-1,200 g/ml of PM2.5 decreased the viability of A549 cells significantly in a concentration-dependent manner; however, 50-400 g/ml of Rg1 had no significant effect. Pretreatment with 100, 200 or 400 g/ml Rg1 significantly diminished the 200 g/ml PM2.5-induced A549 cell viability and decreased LDH leakage and MDA generation in a concentration-dependent manner. These results indicated that PM2.5 induced cell injury and Rg1, antagonized PM2.5-induced cell injury to a certain extent.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2012]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2012版] 出版当年五年平均[2008-2012] 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]China Acad Chinese Med Sci, Inst Basic Theory, Beijing 100700, Peoples R China [*1]China Acad Chinese Med Sci, Inst Basic Theory, 16 Nanxiaojie, Beijing 100700, Peoples R China
通讯作者:
通讯机构: [1]China Acad Chinese Med Sci, Inst Basic Theory, Beijing 100700, Peoples R China [*1]China Acad Chinese Med Sci, Inst Basic Theory, 16 Nanxiaojie, Beijing 100700, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)